These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 20818432)

  • 1. Transgenic expression of human cathepsin B promotes progression and metastasis of polyoma-middle-T-induced breast cancer in mice.
    Sevenich L; Werner F; Gajda M; Schurigt U; Sieber C; Müller S; Follo M; Peters C; Reinheckel T
    Oncogene; 2011 Jan; 30(1):54-64. PubMed ID: 20818432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer.
    Vasiljeva O; Papazoglou A; Krüger A; Brodoefel H; Korovin M; Deussing J; Augustin N; Nielsen BS; Almholt K; Bogyo M; Peters C; Reinheckel T
    Cancer Res; 2006 May; 66(10):5242-50. PubMed ID: 16707449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice.
    Vasiljeva O; Korovin M; Gajda M; Brodoefel H; Bojic L; Krüger A; Schurigt U; Sevenich L; Turk B; Peters C; Reinheckel T
    Oncogene; 2008 Jul; 27(30):4191-9. PubMed ID: 18345026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression.
    Bengsch F; Buck A; Günther SC; Seiz JR; Tacke M; Pfeifer D; von Elverfeldt D; Sevenich L; Hillebrand LE; Kern U; Sameni M; Peters C; Sloane BF; Reinheckel T
    Oncogene; 2014 Sep; 33(36):4474-84. PubMed ID: 24077280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
    Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
    Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice.
    Zhang H; Kuang SQ; Liao L; Zhou S; Xu J
    Cancer Res; 2004 Oct; 64(19):7169-77. PubMed ID: 15466215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice.
    Sevenich L; Schurigt U; Sachse K; Gajda M; Werner F; Müller S; Vasiljeva O; Schwinde A; Klemm N; Deussing J; Peters C; Reinheckel T
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2497-502. PubMed ID: 20133781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice.
    Bugge TH; Lund LR; Kombrinck KK; Nielsen BS; Holmbäck K; Drew AF; Flick MJ; Witte DP; Danø K; Degen JL
    Oncogene; 1998 Jun; 16(24):3097-104. PubMed ID: 9671388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases.
    van der Pluijm G; Sijmons B; Vloedgraven H; Deckers M; Papapoulos S; Löwik C
    J Bone Miner Res; 2001 Jun; 16(6):1077-91. PubMed ID: 11393785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.
    Lamszus K; Jin L; Fuchs A; Shi E; Chowdhury S; Yao Y; Polverini PJ; Laterra J; Goldberg ID; Rosen EM
    Lab Invest; 1997 Mar; 76(3):339-53. PubMed ID: 9121117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic Polyoma middle-T mice model premalignant mammary disease.
    Maglione JE; Moghanaki D; Young LJ; Manner CK; Ellies LG; Joseph SO; Nicholson B; Cardiff RD; MacLeod CL
    Cancer Res; 2001 Nov; 61(22):8298-305. PubMed ID: 11719463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
    Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
    Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stefin B deficiency reduces tumor growth via sensitization of tumor cells to oxidative stress in a breast cancer model.
    Butinar M; Prebanda MT; Rajković J; Jerič B; Stoka V; Peters C; Reinheckel T; Krüger A; Turk V; Turk B; Vasiljeva O
    Oncogene; 2014 Jun; 33(26):3392-400. PubMed ID: 23955077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
    Blavier L; Lazaryev A; Dorey F; Shackleford GM; DeClerck YA
    Cancer Res; 2006 Mar; 66(5):2691-9. PubMed ID: 16510589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
    Bierie B; Stover DG; Abel TW; Chytil A; Gorska AE; Aakre M; Forrester E; Yang L; Wagner KU; Moses HL
    Cancer Res; 2008 Mar; 68(6):1809-19. PubMed ID: 18339861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MEKK1 controls matrix degradation and tumor cell dissemination during metastasis of polyoma middle-T driven mammary cancer.
    Cuevas BD; Winter-Vann AM; Johnson NL; Johnson GL
    Oncogene; 2006 Aug; 25(36):4998-5010. PubMed ID: 16568086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression.
    Yoshidome K; Shibata MA; Couldrey C; Korach KS; Green JE
    Cancer Res; 2000 Dec; 60(24):6901-10. PubMed ID: 11156389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival.
    Chen Z; Varney ML; Backora MW; Cowan K; Solheim JC; Talmadge JE; Singh RK
    Cancer Res; 2005 Oct; 65(19):9004-11. PubMed ID: 16204074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A direct test of potential roles for beta3 and beta5 integrins in growth and metastasis of murine mammary carcinomas.
    Taverna D; Crowley D; Connolly M; Bronson RT; Hynes RO
    Cancer Res; 2005 Nov; 65(22):10324-9. PubMed ID: 16288021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.